SUDARSHAN PHARMA INDUSTRIES
|
The Current P/E Ratio of SUDARSHAN PHARMA INDUSTRIES is 40.48.
| Share Price | ₹37.9 | Jul 02,2026 |
| Market Cap | ₹946.1 Cr | |
| Earnings-TTM | ₹23.4 Cr | TTM-Consolidated Results |
| Price/Earnings | 40.48x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SUDARSHAN PHARMA INDUSTRIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹946.1 Cr] as on Jul 02,2026
(/) Earnings [ ₹23.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 40.48x ]
Thus, for SUDARSHAN PHARMA INDUSTRIES , the investors are currently willing to pay 40.48 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUDARSHAN PHARMA INDUSTRIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SUDARSHAN PHARMA INDUSTRIES over the last five years.
Historical PE (Price/Earnings) ratio chart of SUDARSHAN PHARMA INDUSTRIES
PE Ratio Performance Analysis for SUDARSHAN PHARMA INDUSTRIES
- SUDARSHAN PHARMA INDUSTRIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 13.34x.
- SUDARSHAN PHARMA INDUSTRIES 's operated at median p/e ratio of 1.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUDARSHAN PHARMA INDUSTRIES 's p/e ratio peaked in Mar2025 at 46.06x.
- SUDARSHAN PHARMA INDUSTRIES 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does SUDARSHAN PHARMA INDUSTRIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SUDARSHAN PHARMA INDUSTRIES | 23.37 | 40.48 | 946.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 38.83 | 449,048.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 68.99 | 177,179.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 73.81 | 157,804.0 |
| CIPLA LTD | 3,869.79 | 30.40 | 117,642.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 27.11 | 112,368.0 |
| MANKIND PHARMA LTD | 1,926.41 | 53.33 | 102,729.0 |
| LUPIN LTD | 5,355.47 | 20.48 | 109,676.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.82 | 109,691.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.64 | 89,761.8 |
| LAURUS LABS LTD | 889.85 | 92.60 | 82,398.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SUDARSHAN PHARMA INDUSTRIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 20.48x |
| Max industry PE | 92.60x |
| Median industry PE | 38.83x |
| Average industry PE | 44.86x |
You may also like the below Video Courses